Bijuva (Estradiol/Progesterone): The Complete Patient Guide to Uses, Dosing, Availability, and Finding It in Stock

What Is Bijuva?

Bijuva is a brand-name oral capsule that combines two naturally occurring hormones — estradiol (an estrogen) and progesterone — into a single, once-daily dose. It belongs to the class of medications known as combination hormone therapy (HT), and it's specifically engineered to deliver both hormones in a bioidentical form, meaning their molecular structure is identical to the hormones your body produces naturally. That matters to many patients and providers because bioidentical hormones may be better tolerated than the synthetic versions found in older hormone therapies.

The FDA approved Bijuva in October 2018, making it the first and only FDA-approved oral combination of bioidentical estradiol and progesterone in a single capsule. Its approved indication is treatment of moderate-to-severe vasomotor symptoms (VMS) — the medical term for hot flashes and night sweats — in postmenopausal women who have a uterus. The "who have a uterus" part is critical: the progesterone component is included specifically to protect the uterine lining (endometrium) from the cell overgrowth that estrogen alone can cause, which could otherwise increase the risk of endometrial cancer. Bijuva is made by TherapeuticsMD and currently has no FDA-approved generic equivalent, which affects both its price and its availability at pharmacies.

Bijuva is most commonly prescribed to women between the ages of 45 and 65 who are in perimenopause or postmenopause and are experiencing disruptive hot flashes or night sweats that interfere with sleep, work, or quality of life. It's particularly popular among patients and providers who prefer a bioidentical, single-capsule approach over multi-drug regimens or transdermal options. Because it's a branded medication with no generic on the market, finding it stocked at your local pharmacy can take more legwork than you might expect. If you're having trouble finding Bijuva, FindUrMeds can locate it at a pharmacy near you.

How Does Bijuva Work?

Bijuva works by replenishing the estradiol and progesterone your body stops producing after menopause. The estradiol component binds to estrogen receptors in the brain, particularly in the hypothalamus — the region that acts as your body's internal thermostat. When estrogen levels drop after menopause, that thermostat becomes hypersensitive to tiny fluctuations in core body temperature, triggering the rapid heat-release response we know as a hot flash. By restoring estradiol levels to a stable physiological range, Bijuva essentially recalibrates that thermostat and reduces both the frequency and severity of hot flashes. In clinical trials (the REPLENISH trial), patients experienced a statistically significant reduction in moderate-to-severe VMS within 4 weeks, with continued improvement through 12 weeks. Most patients report noticeable relief within 2 to 4 weeks of starting the medication.

The progesterone component in Bijuva plays a protective and complementary role. In women with an intact uterus, estrogen given alone (unopposed estrogen) stimulates growth of the endometrial lining, which raises the risk of endometrial hyperplasia and cancer. Progesterone counteracts this effect by stabilizing and shedding the lining. The formulation in Bijuva uses micronized progesterone suspended in peanut oil within a soft-gel capsule, which improves absorption compared to older crystalline progesterone formulations. After oral ingestion, both hormones are absorbed through the gastrointestinal tract and reach peak plasma concentrations within approximately 5 to 8 hours. The half-life of oral estradiol is roughly 13 to 20 hours, making once-daily dosing sufficient to maintain steady-state hormone levels throughout a 24-hour period.

Available Doses of Bijuva

Bijuva is currently available in only one FDA-approved combination strength:

Estradiol 1 mg / Progesterone 100 mg capsule — This is the approved dose and the standard starting dose for all patients. It is taken once daily at bedtime, with or without food (though taking it with food may improve tolerability and absorption).

Unlike many medications that come in a range of strengths to allow dose titration, Bijuva has a single fixed-dose formulation. Your doctor may adjust your overall hormone therapy strategy by adding or changing other components, but the Bijuva capsule itself does not come in higher or lower strengths. This simplifies the prescribing decision but also means there is no flexibility within the product itself to "step up" or "step down."

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Bijuva Findability Score

Bijuva Findability Score: 72 out of 100

Our Findability Score is a proprietary metric that rates how easy or difficult a given medication is to locate in stock at a US retail pharmacy, on a scale from 1 to 100. A score of 1 means extreme scarcity — patients may wait days or weeks and contact dozens of pharmacies. A score of 100 means you can walk into virtually any pharmacy and pick it up off the shelf. The score is calculated using real-time data from our network of 15,000+ pharmacies, cross-referenced with ASHP Drug Shortage Database records, manufacturer supply disclosures, DEA quota data (for controlled substances), and our own internal call success rates. Scores above 70 generally mean FindUrMeds can locate the medication for most patients within 24–48 hours.

Bijuva scores a 72, which puts it in the "moderately available" range — better than many specialty or controlled-substance medications, but noticeably harder to find than generic hormone therapy products. Several factors drive this score. First, Bijuva is a brand-name-only product manufactured by a single company (TherapeuticsMD), which means supply is entirely dependent on one manufacturer's production schedule and distribution chain. There is no generic version that pharmacies can substitute when brand inventory runs low. Second, because progesterone in combination oral products is less commonly stocked than standalone estrogen patches or pills, many pharmacies — particularly smaller independent locations — simply don't carry it as a routine inventory item. According to our data across 40,000+ pharmacy searches for combination hormone therapy products, approximately 34% of retail pharmacy locations that carry hormone therapy products do not stock Bijuva on a regular basis.

Practically speaking, a score of 72 means you should not assume your nearest pharmacy has it. Based on ASHP Drug Shortage Database records and our internal search data, Bijuva has not appeared on the FDA's official drug shortage list as of our most recent review — which is genuinely good news. The availability challenges are less about an active shortage and more about the realities of a single-source branded product with moderate (but not blockbuster) prescription volume. Our platform's analysis of Bijuva availability found that patients who attempt to find it on their own contact an average of 4 to 7 pharmacies before locating it in stock — compared to the 7–12 pharmacies typical for Tier 3–5 medications. That's still 4 to 7 calls you'd rather not make.

Our success rate for finding Bijuva for patients who use FindUrMeds is 91%, slightly below our platform-wide 92% average — consistent with a Tier 9 medication that is broadly available but not universally stocked. Skip the pharmacy calls. FindUrMeds finds Bijuva for you.

Bijuva Pricing

Bijuva's pricing reflects its status as a branded, single-source medication with no generic competition. Costs vary significantly depending on your insurance plan, pharmacy, and geographic region. Here's a realistic breakdown:

With Insurance: Most commercial insurance plans that cover hormone therapy will apply a Tier 3 or Tier 4 brand-name copay to Bijuva. Typical copay ranges run $40–$100 per 30-day supply, though some plans with higher cost-sharing may charge $100–$150. Medicare Part D coverage of Bijuva varies by plan — check your plan's formulary directly, as some plans do not include it or require prior authorization.

Without Insurance (Cash Price): The retail cash price for a 30-day supply of Bijuva (30 capsules) is typically in the range of $280–$400 at major chain pharmacies, though prices at some pharmacies may exceed this range.

GoodRx Estimated Price: Using GoodRx or similar discount cards, patients can often reduce the out-of-pocket cost to approximately $180–$260 per 30-day supply, depending on the pharmacy. GoodRx pricing is not universally accepted and may not be combinable with insurance.

Manufacturer Copay Assistance: TherapeuticsMD has historically offered a copay savings card program for commercially insured patients, which could reduce copays to as low as $0 per month (subject to eligibility requirements, monthly caps, and program terms). Check the official Bijuva website or ask your pharmacist whether the savings card program is currently active. Patients without insurance or with government insurance (Medicare, Medicaid) are typically not eligible for manufacturer copay cards.

Patient Assistance Programs: For uninsured or underinsured patients who meet income requirements, TherapeuticsMD's patient assistance program may provide Bijuva at no cost. Ask your prescriber's office to help you apply, or contact TherapeuticsMD directly.

Note: All prices are estimates and may vary by pharmacy, region, and current market conditions. Always confirm pricing with your specific pharmacy before filling.

Who Can Prescribe Bijuva?

Bijuva is a prescription medication that can be prescribed by any licensed provider with prescribing authority in the United States. The following types of providers commonly prescribe it:

OB/GYNs (Obstetricians/Gynecologists): The most common prescribers of Bijuva. OB/GYNs specialize in women's reproductive health and are highly familiar with hormone therapy options, risks, and monitoring.
Primary Care Physicians (PCPs) and Family Medicine Doctors: Many PCPs are comfortable prescribing hormone therapy for menopause management, particularly in patients with established care relationships.
Internists: Internal medicine physicians, especially those managing chronic disease in midlife women, frequently prescribe HT.
Menopause Specialists: Physicians or practitioners who hold NAMS (North American Menopause Society) Certified Menopause Practitioner (NCMP) certification have advanced training in HT selection and are excellent resources for complex cases.
Nurse Practitioners (NPs) and Physician Assistants (PAs): Advanced practice providers with prescribing authority can prescribe Bijuva in all 50 states, subject to their scope of practice and any applicable collaborative agreements.
Endocrinologists: Specialists in hormonal disorders who may manage HT as part of broader endocrine care.
Telemedicine Providers: Bijuva can be prescribed via telehealth in all 50 states, as it is not a controlled substance and does not require in-person evaluation under federal law. Several menopause-focused telehealth platforms specialize in HT prescribing and can connect patients with licensed providers quickly. A video visit or even an asynchronous questionnaire-based visit may be sufficient for initial prescribing in some states, depending on platform and state-specific rules. Always confirm with the telehealth platform whether they can send the prescription to a specific pharmacy.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Bijuva Side Effects

Like all hormone therapy medications, Bijuva carries a range of possible side effects — from common and mild to less frequent but more serious. Understanding what to expect helps you distinguish normal adjustment from something that needs medical attention.

Most Common Side Effects

These are the side effects most frequently reported in clinical trials and post-market experience. They are generally mild to moderate in severity:

Breast pain or tenderness — Very common, especially in the first 1–3 months of use. Your body is readjusting to circulating estrogen.
Vaginal bleeding or spotting — Some irregular spotting is normal, particularly during the first few months. Persistent or heavy bleeding should be evaluated.
Headache — Hormonal fluctuations can trigger headaches; these typically stabilize as levels even out.
Nausea — Taking Bijuva at bedtime with a small snack can reduce nausea.
Fatigue or drowsiness — The progesterone component has mild sedative properties, which is actually why bedtime dosing is recommended. Some patients find this helpful for sleep.
Vaginal discharge — Changes in vaginal secretions are common and usually benign.
Upper respiratory symptoms — Reported in clinical trials at low rates, mechanism unclear.
Urinary tract infections (UTIs) — Reported modestly more often in HT users; stay well-hydrated and report persistent symptoms to your provider.

Less Common but Serious Side Effects

These are rare but important. Contact your provider immediately or seek emergency care if you experience any of the following:

Blood clots (venous thromboembolism): Signs include swelling, redness, warmth, or pain in the legs, or sudden shortness of breath and chest pain. Oral estrogen is associated with a small increase in clot risk compared to transdermal delivery.
Stroke: Sudden numbness, severe headache, vision changes, difficulty speaking, or confusion warrant emergency evaluation.
Heart attack: Chest pain, pressure, or tightness, especially with shortness of breath, should prompt a 911 call.
Breast changes: Any new lump, nipple discharge, or skin dimpling should be evaluated promptly. Long-term hormone therapy is associated with a modestly increased risk of breast cancer; discuss your personal risk factors with your provider.
Liver problems: Jaundice (yellowing of skin or eyes), dark urine, or severe abdominal pain could indicate liver dysfunction. Oral hormone therapy undergoes first-pass liver metabolism, making liver health relevant.
Gallbladder disease: Oral estrogen increases the risk of gallstones. Report severe or persistent upper-right abdominal pain.
Unusual vaginal bleeding: Bleeding that is heavy, prolonged, or occurs after your period has completely stopped for 12+ months should always be evaluated to rule out endometrial pathology.

Contact your provider if any of the above occur. This is not an exhaustive list of serious effects.

Side Effects That Typically Improve Over Time

Many of the most common Bijuva side effects — breast tenderness, spotting, mild nausea, and drowsiness — tend to improve significantly after 4 to 12 weeks of consistent use as your body adjusts to stable hormone levels. If side effects are bothering you during this window, talk to your provider before stopping the medication, as abrupt discontinuation can cause a sudden return of vasomotor symptoms. Dose timing adjustments (consistently at bedtime, with food) can reduce the impact of nausea and drowsiness.

This information is for educational purposes only and is not a substitute for personalized medical advice. Always discuss side effect concerns with your doctor or pharmacist.

Alternatives to Bijuva

Bijuva is the only FDA-approved single oral capsule combining bioidentical estradiol and progesterone, but several alternatives exist — both within the same hormonal class and using different mechanisms entirely.

Same-Class Alternatives

These options combine estrogen and progestogen therapy in different formulations, delivery methods, or molecular compositions:

Prempro (conjugated equine estrogens / medroxyprogesterone acetate): A long-established oral combination HT. Uses synthetic progestin rather than bioidentical progesterone; widely stocked and significantly less expensive.
Premphase: A cyclic version of conjugated equine estrogens + medroxyprogesterone acetate, designed to produce a monthly bleed — often preferred by recently menopausal women.
Combipatch (estradiol / norethindrone acetate): A transdermal patch changed twice weekly; avoids first-pass liver metabolism, which may reduce clot risk; delivers bioidentical estradiol with synthetic progestin.
Climara Pro: A once-weekly transdermal patch combining estradiol and levonorgestrel; convenient for patients who prefer weekly dosing.
Mimvey / Mimvey Lo (estradiol / norethindrone acetate): Oral combination tablets available in two strengths; generic versions are available, making this a more affordable alternative.
Separate estradiol + separate progesterone (e.g., Estrace + Prometrium): Prescribing the two components separately allows dose flexibility. Prometrium (micronized progesterone) and generic estradiol tablets are widely available and often more affordable than Bijuva, though the two-pill routine is less convenient.

Different-Mechanism Alternatives

For patients who cannot or prefer not to use hormone therapy, these non-hormonal options may help manage vasomotor symptoms:

Veozah (fezolinetant): FDA-approved in 2023, this is the first non-hormonal, non-antidepressant prescription medication approved specifically for hot flashes. It works by blocking neurokinin B signaling in the hypothalamus — a completely different mechanism from HT.
Brisdelle (paroxetine 7.5 mg): The only FDA-approved SSRI specifically for VMS. Lower dose than typical antidepressant dosing. Not appropriate for patients taking tamoxifen.
Off-label SSRIs/SNRIs (venlafaxine, escitalopram, citalopram): Frequently used off-label with clinical evidence supporting efficacy; may be appropriate for patients with contraindications to estrogen.
Gabapentin: Off-label use for hot flash reduction, particularly useful for nighttime symptoms; evidence base is modest but some patients respond well.
Clonidine: An alpha-2 agonist with mild evidence for VMS reduction; typically considered when other options are unsuitable.
Cognitive Behavioral Therapy (CBT): Evidence-based behavioral intervention shown to reduce the distress associated with hot flashes, even when it doesn't eliminate them entirely.

If you'd prefer to stick with Bijuva, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Bijuva

Because Bijuva contains both estradiol and progesterone, it can interact with a range of medications. Always give your pharmacist and every prescriber a complete list of your medications, supplements, and over-the-counter products.

Serious Interactions

Hepatotoxic drugs (medications toxic to the liver): Because oral estrogen and progesterone are metabolized by the liver, concurrent use of other hepatotoxic agents may increase liver strain and impair hormone metabolism, affecting both safety and efficacy.
Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort): These drugs dramatically increase the liver's metabolism of estradiol and progesterone, potentially reducing Bijuva's hormone levels to ineffective concentrations. St. John's Wort is a particularly important one to flag because patients often don't think of it as a "drug."
Tamoxifen: Concurrent use of estrogen with tamoxifen (used in breast cancer treatment or prevention) is contraindicated, as estrogen may counteract tamoxifen's anti-estrogenic mechanism.

Moderate Interactions

Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, grapefruit juice): May increase plasma concentrations of both estradiol and progesterone, potentially amplifying both effects and side effects.
Thyroid hormone replacement (levothyroxine): Estrogen increases thyroid-binding globulin, which can reduce free thyroid hormone levels. Patients on thyroid replacement who start Bijuva may need a thyroid function check and possible dose adjustment.
Corticosteroids: Estrogen may increase the effects of corticosteroids by decreasing their clearance. Monitor for enhanced corticosteroid effects.
Anticoagulants (warfarin): Estrogen may affect clotting factor levels and potentially alter anticoagulant requirements. INR monitoring is recommended if starting or stopping Bijuva while on warfarin.
Insulin and antidiabetics: Estrogen can affect glucose metabolism and insulin sensitivity. Blood sugar monitoring is warranted in diabetic patients starting HT.

Food and Substance Interactions

Grapefruit and grapefruit juice: Contains furanocoumarins that inhibit CYP3A4 in the gut wall, potentially increasing estradiol and progesterone absorption and blood levels. Moderate grapefruit consumption is unlikely to be clinically significant for most patients, but heavy grapefruit use should be discussed with your provider.
Alcohol: Alcohol is metabolized by the liver and may temporarily raise estradiol levels in women on hormone therapy — some research suggests that regular alcohol use increases circulating estrogen, which could have implications for breast tissue over time. Alcohol also independently increases breast cancer risk.
High-fat meals: May modestly increase progesterone absorption from Bijuva, which is partly why consistent bedtime dosing with a routine eating schedule is recommended for stable blood levels.
St. John's Wort (supplement): As noted above, this is a potent CYP3A4 inducer that can meaningfully reduce the effectiveness of Bijuva. This includes standardized extract supplements commonly sold at natural health stores.

How to Find Bijuva in Stock

Finding Bijuva takes a bit more effort than picking up a generic medication, but there are several practical strategies that work. Here's exactly what to do:

1. Use FindUrMeds (Most Effective)

This is the fastest and least frustrating route, by a significant margin:

We do the calling for you. When you submit your prescription information to FindUrMeds, our team contacts pharmacies across our network of 15,000+ locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — to find which ones currently have Bijuva in stock. You don't make a single phone call.
We search locally and regionally. Our search prioritizes pharmacies within a reasonable distance from your zip code, then expands the radius as needed. We identify both the closest available location and any price advantages across nearby options.
We confirm before you go. We verify that the pharmacy has your specific medication ready and communicate the result to you — typically within 24–48 hours. Our success rate for Bijuva is 91%, meaning nearly 9 in 10 patients who use FindUrMeds walk away knowing exactly where to fill their prescription.

2. Check GoodRx (Price Listing = Stock Signal)

GoodRx and similar pricing platforms don't display live inventory, but here's a useful insider trick: if a pharmacy shows a price for Bijuva on GoodRx, it's a strong signal that they stock it. Pharmacies that don't carry a medication typically don't generate pricing data in GoodRx's system. Steps:

Go to GoodRx.com and search "Bijuva."
Enter your zip code to see local pricing results.
Pharmacies showing a price are likely to have it in stock — call those first and ask directly.
Print or screenshot the GoodRx coupon before you call, so you can compare pricing in real time.

This doesn't replace calling ahead to confirm, but it gives you a prioritized short list of pharmacies worth calling — instead of calling blind.

3. Check Pharmacy Apps (CVS, Walgreens, Walmart)

Major chain pharmacy apps and websites now include prescription price-check features that function similarly to GoodRx:

CVS app: Use the "Rx Price Quote" feature. If CVS can generate a quote for Bijuva at a specific store, that location is likely carrying it. You can also use CVS's pharmacy chat feature to ask about availability.
Walgreens app: The "Prescription Savings Club" price check or standard price quote feature works the same way. Walgreens also allows you to transfer prescriptions in-app, so if you find a location with stock, you can initiate a transfer without calling.
Walmart Pharmacy: Walmart's website allows price checks by zip code. Walmart pharmacies are sometimes underutilized for hormone therapy but frequently stock branded products at competitive prices.

Tip: Don't just check the app and assume. Apps reflect recent inventory data but not always same-day reality. Use the app to identify promising locations, then call or message to confirm before making a trip.

4. Call Pharmacies Using the Generic Name

This tip alone saves patients significant time. Many pharmacy staff search inventory by generic ingredient name rather than brand name, and "Bijuva" may not return results if their system is cataloged differently. Use this exact phone script:

"Hi, I'm looking for estradiol 1 mg / progesterone 100 mg — it's the brand name Bijuva, but you might have it listed as a combination capsule. Do you currently have it in stock?"

This phrasing covers both the brand and ingredient search, and it signals to the pharmacist that you know what you're looking for — which typically prompts a more thorough check.

Additional calling tips:

Call in the morning (9–11 a.m.) when pharmacy staff are least overwhelmed and more likely to do a thorough inventory check.
Ask specifically: "Do you have it in stock today, or would you need to order it?" Pharmacies can often order Bijuva with 1–2 business days lead time if they don't have it on the shelf.
Ask if nearby sister locations of the same chain have it.

🔍 Skip All of This — Let FindUrMeds Do It For You

FindUrMeds contacts pharmacies on your behalf and finds Bijuva in stock near you — usually within 24–48 hours, across 15,000+ locations nationwide.

Our Pharmacy Call Index shows that patients searching for Bijuva independently make an average of 4–7 pharmacy contacts before finding it. FindUrMeds replaces all of those calls with a single submission.

Find Bijuva Near You →

Frequently Asked Questions

Is Bijuva still in shortage?

As of our most recent review, Bijuva does not appear on the FDA's official drug shortage list, and it has not been listed on the ASHP Drug Shortage Database as a current shortage product. This is good news — the availability challenges patients experience with Bijuva are not the result of an active national shortage but rather the reality of a single-source branded product with limited distribution depth. Not every pharmacy stocks it routinely, which means you may need to check multiple locations. Our platform's analysis found that approximately 34% of pharmacies carrying hormone therapy products do not stock Bijuva on a regular basis, even without a formal shortage. The situation can change, so if you're having trouble, FindUrMeds can check current real-time availability across 15,000+ pharmacies.

How much does Bijuva cost without insurance?

Without insurance or a discount card, the retail cash price of Bijuva typically ranges from $280 to $400 per 30-day supply at major chain pharmacies. Using a GoodRx coupon or similar discount card can reduce that to approximately $180–$260, depending on the pharmacy. If you're paying out of pocket, it's worth calling several pharmacies and comparing GoodRx prices, since there can be meaningful variation from one location to another — sometimes $50–$80 difference for the same medication. TherapeuticsMD has also offered manufacturer copay assistance programs for commercially insured patients that could reduce the cost to as little as $0/month, subject to eligibility. Check the Bijuva manufacturer website or ask your pharmacist about currently active programs.

Can I get Bijuva through mail-order pharmacy?

Yes — mail-order pharmacy is one of the more reliable ways to obtain Bijuva, especially if you've confirmed your insurance plan covers it. Because mail-order pharmacies (like CVS Caremark, Express Scripts, Optum Rx, and Walgreens Mail Service) operate large central distribution centers, they are more likely to have branded specialty products in stock than smaller retail locations. A 90-day supply through mail order may also reduce your per-dose cost compared to filling monthly at retail. The tradeoff is that mail-order requires planning ahead — you typically need to order 7–10 days before you run out, and your first fill may take longer while the prescription is being processed. Ask your insurance company or benefits manager whether your plan has a preferred mail-order pharmacy and whether Bijuva is covered under your plan's mail-order formulary.

What's the difference between Bijuva and Prometrium + separate estradiol?

This is one of the most common questions providers field about hormone therapy. Prometrium is an FDA-approved standalone micronized progesterone capsule (100 mg or 200 mg), and it uses the same form of bioidentical progesterone as Bijuva. Many providers prescribe Prometrium alongside a separate estradiol product (tablet, patch, gel, or spray) as an alternative to Bijuva — and for a large number of patients, this combination works just as well. The advantages of Bijuva are consolidation (one capsule instead of two) and the fact that the dose ratio has been specifically studied and FDA-approved as a unit. The advantages of the separate approach include significantly lower cost (generic estradiol tablets and generic progesterone are much cheaper than branded Bijuva), greater dosing flexibility, and wider pharmacy availability. For patients sensitive to cost or who have trouble finding Bijuva in stock, the separate-component approach is worth discussing with your prescriber.

What if my pharmacy is out of Bijuva?

Don't panic — and don't stop taking the medication without guidance from your provider. Here's a practical step-by-step:

Ask your pharmacy to order it. Many pharmacies can have Bijuva in stock within 1–2 business days through their normal wholesaler. This is the easiest solution if you have some supply left.
Use FindUrMeds. Submit your information and we'll identify a pharmacy near you that currently has it in stock — usually within 24–48 hours.
Ask about a short bridge supply. If you're running low, your pharmacist may be able to dispense an emergency supply (typically 3–7 days in most states) while your pharmacy or another location obtains the medication.
Talk to your provider about alternatives. If Bijuva is consistently difficult to find in your area, your provider can discuss switching to a therapeutically similar regimen — such as separate estradiol and Prometrium — that may be easier to fill locally.
Consider mail order for the future. If you've had recurring stock issues, transitioning to a 90-day mail-order fill eliminates most of the month-to-month search frustration.

Need help finding Bijuva in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Bijuva Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Bijuva

Findability Score: 83/100